Effects of the calcium antagonist felodipine on renal haemodynamics, tubular sodium handling, and blood pressure in cyclosporin-treated dermatological patients

Nephrology Dialysis Transplantation

Volumn 12, Issue 3, 1997, Pages 480-484

  Madsen, J K ^a   Zachariae, H ^a   Pedersen, E B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Calcium antagonist; Cyclosporin; Dermatological patients; Felodipine; Renal function

Indexed keywords

CALCIUM ANTAGONIST; CYCLOSPORIN; FELODIPINE; IMMUNOSUPPRESSIVE AGENT; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY PLASMA FLOW; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FELODIPINE; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL CIRCULATION; SKIN DISEASES; SODIUM;

EID: 0031052679     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.3.480     Document Type: Article

References (31)

1. Curtis JJ, Luke RG, Dubovsky E, Dietheim AG, Whelchel JD, Jones P. Cyclosporin in therapeutic doses increases renal allograft vascular resistance. Lancet 1986; 2: 477-479
2. Iwatsuki S, Esquivel CO, Klintmalm GB, Gordon RD, Shaw BW Jr, Starzl TE. Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc 1985; 17: 191-195
3. Thompson ME, Shapiro AP, Johnsen AM et al. The contrasting effects of cyclosporin-A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. Int J Cardiol 1986; 11: 219-229
4. Berg KJ, Forre O, Bjerkhoel F et al. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. KidneyInt 1986; 29: 1180-17
5. Palestine AG, Austin HA, Balow JE et al. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 1986; 314: 1293-18
6. Balletta M, Libetta C, Fuiano G et al. Effects of a two-month treatment with low oral doses of cyclosporin on renal function. Nephrol Dial Transplant 1991; 6: 324-329
7. Feutren G, Abeywickrama K, Friend D, von Graffenried B. Renal function and blood pressure in psoriatic patients treated with cyclosporin A. Br J Dermatol 1990; 122 [Suppl 36]: 57-69
8. Kappelgaard AM, Nielsen MD, Giese J. Measurement of angiotensin II in human plasma: technical modifications and practical experience. Clin Chim Acta 1976; 67: 299-306
9. Rask-Madsen J, Bruusgaard A, Munck O, Nielsen MD, Worming H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1975; 9: 217-246
10. Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol 1987; 17: 267-279
11. Pedersen EB, Danielsen H, Spencer ES. Effect of indapamide on renal plasma flow, glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543-547
12. Rooth P, Dawidson I, Clothier N, Diller K. In vivo fluorescence microscopy of kidney subcapsular blood flow in mice. Effects of cyclosporine, (NVA2)-cyclosporine, and isradipine, a new calcium antagonist. Transplantation 1988; 46: 566-569
13. Dieperink H, Leyssac PP, Starklint H, Jorgensen KA, Kemp E. Antagonist capacities of nifedipine, captopril, phenoxybenzamine, prostacyclin and indomethacin on cyclosporin A induced impairment of rat renal function. Eur J Clin Invest 1986; 16: 540-548
14. Morales JM, Andres A, Alvarez C et al. Calcium channel blockers and early cyclosporine nephrotoxicity after renal transplantation: a prospective randomized study. Transplant Proc 1990; 22: 1733-15
15. Kiberd BA. Cyclosporine-induced renal dysfunction in human renal allograft recipients. Transplantation 1989; 48: 965-969
16. Sorensen SS, Skovbon H, Eiskjaer H, Thomsen K, Pedersen EB. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients. Nephrol Dial Transplant 1992; 7: 69-78
17. Bunke M, Ganzel B. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients. J Heart Lung Transplant 1992; 11: 1194-19
18. Kirk AJ, Omar I, Bateman DN, Dark JH. Cyclosporine-associated hypertension in cardiopulmonary transplantation. The beneficial effect of nifedipine on renal function. Transplantation 1989; 48: 428-430
19. Edwards BD, Chalmers RJ, O'Driscoll J, Lawson RS, Testa HJ, Ballardie FW. Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin. Nephrol Dial Transplant 1993; 8: 1071-18
20. Hulthen UL, Katzman PL. Renal effects of acute and long-term treatment with felodipine in essential hypertension. J Hyper tens 1988; 6: 231-237
21. Schmitz A. Acute renal effects of oral felodipine in normal man. Eur J Clin Pharmacol 1987; 32: 17-22
22. Elmfeldt D, Nordlander M, Edgar B. Renal effects of felodipine - a review. Kidney Int Suppl 1 992; 36: S54-60
23. Bantle JP, Boudreau RJ, Ferris TF. Suppression of plasma renin activity by cyclosporine. Am J Med 1987; 83: 59-64
24. Stanek B, Kovarik J, Rasoul-Rockenschaub S, Silberbauer K. Renin-angiotensin-aldosterone system and vasopressin in cyclosporine-treated renal allograft recipients. Clin Nephrol 1987; 28: 186-189
25. Dieperink H, Leyssac PP, Kemp E et al. Nephrotoxicity of cyclosporin A in humans: effects on glomerular filtration and tubular reabsorption rates. Eur J Clin Invest 1987; 17: 493-496
26. Romero JC, Raij L, Granger JP, Ruilope LM, Rodicio JL. Multiple effects of calcium entry blockers on renal function in hypertension. Hypertension 1987; 10: 140-151
27. Kaskel FJ, Devarajan P, Arbeit LA, Partin JS, Moore LC. Cyclosporine nephrotoxicity: sodium excretion, autoregulation, and angiotensin II. Am J Physiol 1987; 252: F733-742
28. Pedersen EB, Hansen HE, Olsen S et al. Comparison between the effects of cyclosporine and azathioprine on functional and morphologic renal parameters in a randomized study from 12 to 24 months after renal transplantation.. Clin Transplant 1995: 456-466
29. Nyberg G, Haljamae U, Herlitz H, Norden G, Blohme I. Early renal graft function in recipients treated with the calcium channel blocker felodipine. Scand J Urol Nephrol 1994; 28: 17-20
30. Guengerich FP, Brian WR, Iwasaki M, Sari MA, Baarnhielm C, Berntsson P. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA 4. J Med Chem 1991; 34: 1838-1844
31. Watkins PB. The role of cytochrome P-450 in cyclosporine metabolism. J Am Acad Dermatol 1990; 23: 1301-1309 (Discussion)